Electromed, Inc. Payments for Repurchase of Common Stock
Shares the company repurchased and the cash it paid, as filed in its 10-Q and 10-K XBRL (statement of shareholders' equity and cash flow statement).
- Electromed, Inc. payments for repurchase of common stock for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- Electromed, Inc. payments for repurchase of common stock for the quarter ending 2026-03-31 was $152.00K, a 91.53% decline year-over-year.
- Electromed, Inc. payments for repurchase of common stock for the quarter ending 2025-12-31 was $2.76M.
- Electromed, Inc. payments for repurchase of common stock for the quarter ending 2025-09-30 was $1.00M, a 77.89% decline year-over-year.
- Electromed, Inc. payments for repurchase of common stock for fiscal 2026 was $3.92M, a 60.82% decline from fiscal 2025.
- Electromed, Inc. payments for repurchase of common stock for fiscal 2025 was $10.00M, a 3536.36% increase from fiscal 2024.
- Electromed, Inc. payments for repurchase of common stock for fiscal 2024 was $275.00K, a 79.74% increase from fiscal 2023.
- Electromed, Inc. payments for repurchase of common stock for fiscal 2023 was $153.00K, a 89.43% decline from fiscal 2022.
| Period end | Payments for Repurchase of Common Stock 3 month | Payments for Repurchase of Common Stock 12 month |
|---|---|---|
| 2026-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-25 | $3.92M 10-K · filed 2026-08-25 |
| 2026-03-31 | $152.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-12 | $7.59M derived: sum of 4 quarters · filed 2026-08-25 |
| 2025-12-31 | $2.76M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-10 | $9.23M derived: sum of 4 quarters · filed 2026-08-25 |
| 2025-09-30 | $1.00M 10-Q · filed 2025-11-12 | $6.47M derived: sum of 4 quarters · filed 2026-08-25 |
| 2025-06-30 | $3.67M derived: 10-K 12 month − 10-Q 9 month · filed 2026-08-25 | $10.00M 10-K · filed 2026-08-25 |
| 2025-03-31 | $1.79M derived: 10-Q 9 month − 10-Q 6 month · filed 2026-05-12 | $6.61M derived: sum of 4 quarters · filed 2026-05-12 |
| 2024-12-31 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-02-10 | |
| 2024-09-30 | $4.54M 10-Q · filed 2025-11-12 | |
| 2024-06-30 | $275.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-08-26 | $275.00K 10-K · filed 2025-08-26 |
| 2023-06-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-08-27 | $153.00K 10-K · filed 2024-08-27 |
| 2023-03-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-05-07 | $639.00K derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $8.00K 10-Q · filed 2024-05-07 | $938.00K derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-09-30 | $145.00K 10-Q · filed 2024-05-07 | $1.59M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-06-30 | $486.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-08-22 | $1.45M 10-K · filed 2023-08-22 |
| 2022-03-31 | $299.00K 10-Q · filed 2023-05-09 | |
| 2021-12-31 | $663.00K 10-Q · filed 2023-05-09 | |
| 2021-06-30 | $1.12M 10-K · filed 2022-08-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| EDAP TMS SA (FOCL) | $0.171B | ||
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B |